Skip to content
Living Diabetes
  • Home
  • Newly Diagnosed
  • Diabetes Types
    • Type 2 Diabetes
    • Type 1 Diabetes
    • Insulin Resistance
  • Food & Recipes
    • Food
    • Recipes
  • Treatment
    • Medications
    • Weight Loss & Reversal
    • Complications
  • Calculators
  • News
  • Home
  • Newly Diagnosed
  • Diabetes Types
    • Type 2 Diabetes
    • Type 1 Diabetes
    • Insulin Resistance
  • Food & Recipes
    • Food
    • Recipes
  • Treatment
    • Medications
    • Weight Loss & Reversal
    • Complications
  • Calculators
  • News

Tirzepatide

Tirzepatide Maintenance Study: What SURMOUNT-MAINTAIN Means

6th June 202622nd May 2026 by Living Diabetes Editorial

Plain-language SURMOUNT-MAINTAIN summary covering continued tirzepatide, dose reduction, weight regain, study limits, and patient questions.

Categories News, Obesity

Tirzepatide and Heart Outcomes: What SURPASS-CVOT Shows

6th June 202626th March 2026 by Living Diabetes Editorial Team

SURPASS-CVOT compared tirzepatide with dulaglutide in type 2 diabetes and ASCVD. Learn what the result does and does not prove.

Categories Diabetes Medication

Tirzepatide (Mounjaro): What Adults With Type 2 Diabetes Should Know

6th June 202612th March 2026 by Living Diabetes Editorial

Tirzepatide, sold as Mounjaro, is used for adults with type 2 diabetes. Learn benefits, limits, side effects, and safety questions.

Categories Diabetes Education, Endocrinology, Insulin Resistance, Obesity, Type 2 diabetes

New Research Confirms GLP-1 Medications Protect the Heart, Not Just Blood Sugar

6th June 202629th November 2025 by Living Diabetes Editorial

New Research Confirms GLP-1 Medications Protect the Heart, Not Just Blood Sugar: cardiovascular outcome trial evidence, who benefits most, and how this drug.

Categories News
Mounjaro

Mounjaro for Type 2 Diabetes: Benefits, Risks, and Questions

6th June 202614th July 2023 by Living Diabetes Editorial

Mounjaro is tirzepatide for adults with type 2 diabetes. Learn potential benefits, common side effects, warnings, and questions.

Categories Diabetes Education, Diabetes Medication, Obesity, Type 2 diabetes
Mounjaro

Mounjaro: A New Weight Loss Medication for Adults with Type 2 Diabetes

6th June 202614th July 2023 by Living Diabetes Editorial

Mounjaro: A New Weight Loss Medication for Adults with Type 2 Diabetes: how it works, who it’s used for, common side effects, and current NICE NG28 guidance.

Categories Type 2 diabetes

About Living Diabetes

  • About
  • Editorial Process
  • Sources
  • Glossary
  • Calculators
  • Medical Disclaimer
  • Cookie Policy

Recent Posts

  • Tzield for Recently Diagnosed Stage 3 Type 1 Diabetes: What Families Should Know
  • Camping With Diabetes: Packing, Heat, and Safety Tips
  • Low-Carb vs Low-Fat for Type 2 Diabetes
  • First CKM Guideline: What Diabetes Patients Should Know
  • Summer Activity Guide: Staying Active with Diabetes

Categories

  • Diabetes Complications
  • Diabetes Education
  • Diabetes Medication
  • Diet
    • Keto
    • Recipes
      • All Recipes
      • Breakfast
      • Dinner
      • Lunch
  • Endocrinology
    • Thyroid
  • Eye Health
  • Food & Nutrition
  • General
  • Gestational diabetes
  • Heart Health
  • Insulin Resistance
  • Kidney Health
  • Men's Health
  • News
  • Nutrition
  • Obesity
  • Others
  • Physical Activity
  • Summer Travel Safety
  • Type 1 diabetes
  • Type 2 diabetes
Privacy Policy | Terms of Service
© 2026 GeneratePress
  • Home
  • Newly Diagnosed
  • Diabetes Types
    • Type 2 Diabetes
    • Type 1 Diabetes
    • Insulin Resistance
  • Food & Recipes
    • Food
    • Recipes
  • Treatment
    • Medications
    • Weight Loss & Reversal
    • Complications
  • Calculators
  • News